• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Severe hypocalcaemia [corrected] after treatment with diphosphonate and aminoglycoside.

作者信息

Pedersen-Bjergaard U, Myhre J

出版信息

BMJ. 1991 Feb 2;302(6771):295. doi: 10.1136/bmj.302.6771.295.

DOI:10.1136/bmj.302.6771.295
PMID:1825614
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1668973/
Abstract
摘要

相似文献

1
Severe hypocalcaemia [corrected] after treatment with diphosphonate and aminoglycoside.使用双膦酸盐和氨基糖苷类药物治疗后出现严重低钙血症（校正后）。
BMJ. 1991 Feb 2;302(6771):295. doi: 10.1136/bmj.302.6771.295.
2
Severe hypocalcaemia after treatment with oral clodronate and aminoglycoside.口服氯膦酸盐和氨基糖苷类药物治疗后出现严重低钙血症。
Ann Oncol. 1993 May;4(5):432-3. doi: 10.1093/oxfordjournals.annonc.a058530.
3
[Severe hypocalcemia after treatment with diphosphonates and aminoglycosides].双膦酸盐和氨基糖苷类药物治疗后出现严重低钙血症
Presse Med. 1994;23(17):816.
4
Symptomatic hypocalcemia with oral clodronate.口服氯膦酸盐导致的症状性低钙血症。
J Pain Symptom Manage. 1998 Feb;15(2):140-2. doi: 10.1016/s0885-3924(98)80015-8.
5
Hypocalcaemia after intravenous bisphosphonate: adjuvant bisphosphonate is not currently accepted practice.静脉注射双膦酸盐后出现低钙血症：目前辅助使用双膦酸盐并非公认的做法。
BMJ. 2004 Jun 12;328(7453):1439; author reply 1439-40. doi: 10.1136/bmj.328.7453.1439-b.
6
[A clinical study of netilmicin in patients of surgical field (author's transl)].奈替米星在手术领域患者中的临床研究（作者译）
Jpn J Antibiot. 1982 Jan;35(1):268-72.
7
Netilmicin in the treatment of severe or complicated urinary tract infections.奈替米星治疗严重或复杂性尿路感染
N Z Med J. 1980 May 28;91(660):378-81.
8
Netilmicin: clinical evaluation of efficacy and toxicity of a new aminoglycoside.奈替米星：一种新型氨基糖苷类药物疗效与毒性的临床评估
J Int Med Res. 1979;7(2):117-26. doi: 10.1177/030006057900700202.
9
Use of urinary enzyme activities in the early detection of aminoglycoside nephrotoxicity: a study in children and adults receiving gentamicin or netilmicin.尿酶活性在氨基糖苷类肾毒性早期检测中的应用：一项针对接受庆大霉素或奈替米星治疗的儿童和成人的研究。
Proc West Pharmacol Soc. 1981;24:261-4.
10
Severe hypocalcaemia and hypophosphataemia following intravenous iron and denosumab: a novel drug interaction.静脉注射铁剂和地诺单抗后出现严重低钙血症和低磷血症：一种新型药物相互作用。
Intern Med J. 2016 Mar;46(3):360-3. doi: 10.1111/imj.13001.

引用本文的文献

1
Safety and tolerability of zoledronic acid and other bisphosphonates in osteoporosis management.唑来膦酸及其他双膦酸盐在骨质疏松症治疗中的安全性和耐受性。
Drug Healthc Patient Saf. 2010;2:121-37. doi: 10.2147/DHPS.S6285. Epub 2010 Aug 19.
2
Bisphosphonates in the management of postmenopausal osteoporosis--optimizing efficacy in clinical practice.双膦酸盐在绝经后骨质疏松症管理中的应用——优化临床实践中的疗效
Clin Interv Aging. 2008;3(2):279-97. doi: 10.2147/cia.s2134.
3
Prolonged, symptomatic hypocalcemia with pamidronate administration and subclinical hypoparathyroidism.帕米膦酸二钠给药后出现的持续性、症状性低钙血症及亚临床甲状旁腺功能减退。
Endocrine. 2001 Mar;14(2):159-64. doi: 10.1385/ENDO:14:2:159.
4
Comparative tolerability of drug therapies for hypercalcaemia of malignancy.恶性肿瘤高钙血症药物治疗的耐受性比较
Drug Saf. 1999 Nov;21(5):389-406. doi: 10.2165/00002018-199921050-00004.
5
Adverse effects of bisphosphonates. A comparative review.双膦酸盐的不良反应。一项比较性综述。
Drug Saf. 1996 Mar;14(3):158-70. doi: 10.2165/00002018-199614030-00003.
6
Bisphosphonates and the treatment of bone disease in the elderly.双膦酸盐与老年骨病的治疗
Drugs Aging. 1996 Feb;8(2):113-26. doi: 10.2165/00002512-199608020-00005.
7
Electrocardiographic Q-Tc prolongation associated with infusion of intravenous pamidronate disodium.静脉输注帕米膦酸二钠相关的心电图Q-Tc间期延长
Postgrad Med J. 1993 Jun;69(812):497-8. doi: 10.1136/pgmj.69.812.497-a.
8
Clodronate. A review of its pharmacological properties and therapeutic efficacy in resorptive bone disease.氯膦酸盐。其药理学特性及对溶骨性骨病治疗效果的综述。
Drugs. 1994 Jun;47(6):945-82. doi: 10.2165/00003495-199447060-00007.

本文引用的文献

1
Effects of decreasing serum calcium on circulating parathyroid hormone and vitamin D metabolites in normocalcaemic and hypercalcaemic patients treated with APD.在接受自动化腹膜透析治疗的血钙正常和高钙血症患者中，降低血清钙对循环甲状旁腺激素和维生素D代谢产物的影响。
Bone Miner. 1986 Feb;1(1):69-78.
2
Bisphosphonates--history and experimental basis.双膦酸盐——历史与实验基础。
Bone. 1987;8 Suppl 1:S23-8.
3
Symptomatic hypocalcaemia after treatment with high-dose aminohydroxypropylidene diphosphonate.大剂量氨基羟丙基二膦酸盐治疗后出现症状性低钙血症。
Lancet. 1987 Mar 14;1(8533):622. doi: 10.1016/s0140-6736(87)90255-8.
4
Hypocalcemia with hypoparathyroidism and renal tubular dysfunction associated with aminoglycoside therapy.低钙血症伴甲状旁腺功能减退及与氨基糖苷类药物治疗相关的肾小管功能障碍。
Cancer. 1977 Apr;39(4):1410-4. doi: 10.1002/1097-0142(197704)39:4<1410::aid-cncr2820390409>3.0.co;2-d.
5
Functional hypoparathyroidism and parathyroid hormone end-organ resistance in human magnesium deficiency.人类镁缺乏时的功能性甲状旁腺功能减退和甲状旁腺激素终末器官抵抗
Clin Endocrinol (Oxf). 1976 May;5(3):209-24. doi: 10.1111/j.1365-2265.1976.tb01947.x.